co11ab Novena
Overview
co11ab Novena is a biomedical technology incubator in Singapore, forged through a tripartite alliance between Nanyang Technological University (NTU), the Agency for Science, Technology, and Research (A*STAR), and the National Healthcare Group (NHG), that focuses on nurturing and supporting startups in the biotech, medtech, and digital health sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| LifeSync Robotics | Mar 2025 | Accelerator | Co-investor |
| RNAscence Biotechnology | - | Seed | Co-investor |
| PreSAGE | Apr 2019 | Seed | Co-investor |
| Castomize Technologies | Sep 2024 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is co11ab Novena based?
co11ab Novena is headquartered in Singapore, Singapore.
When was co11ab Novena founded?
co11ab Novena was founded in 2023.
How many portfolio companies does co11ab Novena have?
co11ab Novena has 4 portfolio companies in Caplight's dataset.
What are some companies in co11ab Novena's portfolio?
Portfolio companies visible on Caplight include LifeSync Robotics, RNAscence Biotechnology, PreSAGE, Castomize Technologies.
What was co11ab Novena's most recent investment shown here?
co11ab Novena's most recent investment in this portfolio sample was in LifeSync Robotics in 2025.
What sectors does co11ab Novena focus on?
co11ab Novena focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Consumer & Commerce, Frontier & Industrial Tech.
What company stages does co11ab Novena focus on?
co11ab Novena typically invests at the Early stage.